Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

14%

6 trials in Phase 3/4

Results Transparency

4%

1 of 24 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (9)
P 1 (3)
P 2 (1)
P 3 (4)
P 4 (2)

Trial Status

Completed24
Unknown7
Recruiting5
Withdrawn4
Terminated2
Suspended1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT01031407Completed

Cognitive Neuroscience of Autism Spectrum Disorders

NCT06668519Recruiting

Magnetoencephalography in Children

NCT07028333Not ApplicableRecruitingPrimary

Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation

NCT06934850RecruitingPrimary

The Relationship Between Hand Grip Strength, Trunk Control and Functional Performance in Individuals With Mild Mental Retardation

NCT06848959Recruiting

Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models

NCT03503955Not ApplicableCompletedPrimary

Effectiveness of Video Based Games on Upper Extremity Functions in Mild Mental Retardation Diagnosed Cases

NCT06657430Recruiting

A Study on the Preference of Risperidone Dosage Forms

NCT02791321Not ApplicableCompleted

Fragility Assessment in Adults With ADHD and Mental Retardation

NCT02298647Withdrawn

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

NCT02298686WithdrawnPrimary

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

NCT02943304Completed

Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero

NCT01151462Withdrawn

Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.

NCT05442229UnknownPrimary

A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years

NCT03651245Terminated

European Alpha-Mannosidosis Participant

NCT02797418Not ApplicableTerminatedPrimary

"Cognitus & Moi": a New Cognitive Remediation Tool

NCT03847753Completed

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

NCT01517048Completed

Brain-Derived Neurotrophic Factor in Obesity and Brain Function

NCT00758108Completed

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

NCT00506259Phase 1Completed

Treatment Strategies for Children With Smith-Magenis Syndrome

NCT02245724Phase 1WithdrawnPrimary

Stem Cell Therapy in Mental Retardation

Scroll to load more

Research Network

Activity Timeline